Poteligeo Injection
Product Images NDC 42747-761

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Poteligeo (NDC 42747-761). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kyowa Kirin, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Poteligeo 01)

This text seems to be a table or chart displaying the results of a study comparing two different treatments or medications. The names of the treatments or medications are not clear, but one of them may be called "POTELGEG" or "Vorinostat." The table shows the number of participants in each group and their survival rates over a certain period of time. However, without more information, it is difficult to provide a full description.*

FDA Label Image

Principal Display Panel (4 mg/mL Vial Carton)

This is a prescription drug called Mogamulizumab-kpke which is meant for intravenous infusion only. The usual dosage is not mentioned, and it is advised to see the package insert. Each vial contains 20mg of the drug, and it is important to store it refrigerated. The solution should not be frozen or shaken as it can affect the effectiveness of the drug. The drug is manufactured by Kirin Inc. This is a single-dose vial drug that is only meant for intravenous infusion, and any unused portion of the drug must be discarded immediately.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.